APPH — Apontis Pharma AG Share Price
0.000.00%
Last trade - 00:00- €93.71m
- €78.26m
- €48.47m
- 53
- 16
- 96
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 20.24 | ||
| PEG Ratio (f) | 0.31 | ||
| EPS Growth (f) | 189.82% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.02 | ||
| Price to Tang. Book | 7.01 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.93 | ||
| EV to EBITDA | 22.34 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.22% | ||
| Return on Equity | 2.46% | ||
| Operating Margin | 2.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 39.24 | 51.18 | 55.73 | 36.96 | 48.47 | 57.68 | 69.88 | 3.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +36.63 | n/a | n/a | +389.51 | +94.01 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 14th, 2021
- Public Since
- May 11th, 2021
- No. of Employees
- 137
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 8,330,000
- Address
- Rolf-Schwarz-Schuette-Platz 1, Monheim Am Rhein, 40789
- Web
- Phone
- Auditors
- RSM Ebner Stolz GmbH & Co. KG
Upcoming Events for APPH
Similar to APPH
FAQ
What is the Apontis Pharma AG share price?
As of Today at 19:18 UTC, shares in Apontis Pharma AG are trading at €11.25. This share price information is delayed by 15 minutes.
How has the Apontis Pharma AG share price performed this year?
Shares in Apontis Pharma AG last closed at €11.25 and the price had moved by +34.89% over the past 365 days. In terms of relative price strength the Apontis Pharma AG share price has outperformed the FTSE Global All Cap Index by +32.52% over the past year.
What are the analyst and broker recommendations for Apontis Pharma AG?
The overall consensus recommendation for Apontis Pharma AG is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Apontis Pharma AG dividend yield?
Apontis Pharma AG does not currently pay a dividend.
Does Apontis Pharma AG pay a dividend?
Apontis Pharma AG does not currently pay a dividend.
When does Apontis Pharma AG next pay dividends?
Apontis Pharma AG does not currently pay a dividend.
How do I buy Apontis Pharma AG shares?
To buy shares in Apontis Pharma AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Apontis Pharma AG?
As of the previous close price of €11.25, shares in Apontis Pharma AG had a market capitalisation of €93.71m.
Where are Apontis Pharma AG shares listed?
Here are the trading details for Apontis Pharma AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: APPH
What kind of share is Apontis Pharma AG?
Based on an overall assessment of its quality, value and momentum Apontis Pharma AG is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Apontis Pharma AG share price forecast for 2025?
The analyst consensus target price for shares in Apontis Pharma AG is €13.50. That is 20% above the last closing price of €11.25.
Analysts covering Apontis Pharma AG currently have a consensus Earnings Per Share (EPS) forecast of €0.43 for the next financial year.
Find out moreWhat is the trend in the Apontis Pharma AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apontis Pharma AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +19.46%.
As of the last closing price of €11.25, shares in Apontis Pharma AG were trading +19.68% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Apontis Pharma AG PE Ratio?
The Apontis Pharma AG PE ratio based on its reported earnings over the past 12 months is 20.24. The shares last closed at €11.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Apontis Pharma AG?
We do not have data on Apontis Pharma AG's directors